Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Biorientation of chromosomes in cell division 1 like 2 pseudogene (BOD1L2 pseudogene) is a predicted pseudogene catalogued in the human genome under Ensembl ID ENSG00000197376[1]. Pseudogenes arise from gene duplication or retrotransposition events but generally lose protein-coding potential due to accumulated mutations[9][11]. Unlike functional genes, pseudogenes do not produce active proteins and are typically not involved in classical biological processes or diseases. Some pseudogenes can participate in regulatory networks (e.g., acting as microRNA sponges or influencing their parental gene's expression), but there is no evidence supporting such a role for BOD1L2 pseudogene[1][9][11]. Accordingly, it is not considered a therapeutic target, and there are no described drugs, mechanisms of action, biomarkers, or safety issues associated with this molecule[1][9][11].
Not applicable (no drugs known to act upon this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biorientation of chromosomes in cell division 1 like 2 pseudogene (BOD1L2 pseudogene).